Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Surrozen, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +1 vs. Q1 2025
- Shares held
- 6.03M
- +581.7K (+10.7%) vs. Q1 2025
- Total value
- $53.9M
- −$9.62M (−15.1%) vs. Q1 2025
- New holders
- 3
- 8 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The Column Group LLC | 1,499,773 | $13.4M | 20.40% | 00.0% | Unchanged |
| StemPoint Capital LP | 686,539 | $6.14M | 1.98% | +445,713+185.1% | Added |
| VR Adviser, LLC | 632,931 | $5.66M | 0.42% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 602,626 | $5.39M | 0.09% | −76,504−11.3% | Reduced |
| 5AM Venture Management, LLC | 310,000 | $2.77M | 1.07% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 306,029 | $2.74M | 2.70% | +20,247+7.1% | Added |
| Vivo Capital, LLC | 260,000 | $2.32M | 0.24% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 241,400 | $2.16M | 0.44% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 229,527 | $2.05M | 0.15% | 00.0% | Unchanged |
| Vanguard Group Inc | 218,950 | $1.96M | 0.00% | +150,924+221.9% | Added |
| Acuta Capital Partners, LLC | 170,000 | $1.52M | 2.12% | 00.0% | Unchanged |
| Braidwell LP | 140,000 | $1.25M | 0.04% | +140,000 | New |
| Regents of the University of California | 133,207 | $1.19M | 0.10% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 88,653 | $792.6K | 0.00% | 00.0% | Unchanged |
| Euclidean Capital LLC | 87,696 | $784.0K | 0.26% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 67,566 | $604.0K | 0.00% | −137,368−67.0% | Reduced |
| Armistice Capital, LLC | 60,000 | $536.4K | 0.02% | +60,000 | New |
| ArrowMark Colorado Holdings LLC | 55,123 | $492.8K | 0.01% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 52,130 | $466.0K | 0.05% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 47,930 | $428.5K | 0.06% | 00.0% | Unchanged |
| Morgan Stanley | 34,764 | $310.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 30,963 | $276.9K | 0.00% | +5,702+22.6% | Added |
| Price T Rowe Associates Inc | 21,715 | $195.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,483 | $138.4K | 0.00% | +7,163+86.1% | Added |
| Renaissance Technologies LLC | 14,626 | $130.8K | 0.00% | +400+2.8% | Added |
| Citadel Advisors LLC | 10,451 | $93.4K | 0.00% | +10,451 | New |
| Alyeska Investment Group, L.P. | 10,188 | $91.1K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 281 | $2.51K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 259 | $2.31K | 0.00% | +62+31.5% | Added |
| Tower Research Capital LLC (TRC) | 216 | $1.93K | 0.00% | −186−46.3% | Reduced |
| Bank of America Corp | 52 | $465 | 0.00% | +36+225.0% | Added |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −44,978−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |